Divi's Laboratories has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported 50.07% fall in its net profit at Rs 345 crore for the quarter under review as compared to Rs 691 crore for the same quarter in the previous year. Total income of the company decreased by 21.10% at Rs 1810 crore for Q1FY24 as compared Rs 2294 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 49.29% fall in its net profit at Rs 356 crore for the first quarter ended June 30, 2023 as compared to Rs 702 crore for the same quarter in the previous year. Total income of the company decreased by 20.66% at Rs 1859 crore for Q1FY24 as compared Rs 2343 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1540.30 |
Dr. Reddys Lab | 5872.65 |
Cipla | 1481.55 |
Zydus Lifesciences | 1076.45 |
Lupin | 1712.05 |
View more.. |